5Gaede P, Lund-Andersen H, Parving HH, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N EnglJ Med, 2008, 358:580-591.
6Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med, 2008, 358:2560-2572.
7Soran H, Younis N. Insulin detemir: a new basal insulin analogue. Diabetes Obes Metab, 2006, 8:26-30.
8Havelund s, Ribel U, Plum A, et al. The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin. Pharm Res, 2004, 53:1498-1504.
9Hennige AM, Sartorius T, Tschritter O, et al. Tissue selecxivity of insulin detemir action in vivo. Diabetologia, 2006, 49: 1274-1282.
